Cases & Deals

NewBridge Pharmaceuticals raises capital in Series C round

Clients NewBridge Pharmaceuticals Limited

Jones Day represented NewBridge Pharmaceuticals Limited, a specialty therapeutics company focused on pharmaceutical and biologics, in connection with its issuance of $48 million of Series C Convertible Preferred Stock in a private placement to Elan Corporation, Burrill & Company, and Kuwait Life Sciences Company.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.